SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION (Tables)

12 Months Ended

Dec. 31, 2017

SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION [Abstract]

Supplemental Information, Balance Sheets

Balance sheets:

	December 31,
	2016		2017
(U.S. dollars in thousands)
a.        Other assets:
Institutions	$	333	$	394
State of Israel (see note 6a)		1,046		195
Restricted deposit		477		623
Prepaid expenses		416		433
Assets of discontinued operation		327		215
Sundry		49		74
	$	2,648	$	1,934

	December 31,
	2016		2017
(U.S. dollars in thousands)
b.        Accounts payable and accruals – other:
Payroll and related expenses	$	1,190	$	1,386
Interest payable		511		645
Provision for vacation		1,399		1,650
Accrued expenses		3,575		4,802
Royalties payable		226		301
Property and equipment suppliers		595		526
	$	7,496	$	9,310

Supplemental Information, Statements of Operations

Statements of operations:

	December 31,
	2015		2016		2017
(U.S. dollars in thousands)
Revenues:
Pfizer			$	5,226	$	12,181
Brazil	$	4,364	$	3,973	$	7,061
	$	4,364	$	9,199	$	19,242